Clinical studies of camptothecin and derivatives.
Soepenberg
Otto
O
Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Sparreboom
Alex
A
Verweij
Jaap
J
D000972:Antineoplastic Agents, Phytogenic / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D000077146:Irinotecan; D009153:Mutagens / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000633:toxicity; D019772:Topotecan / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology
D000972:Antineoplastic Agents, Phytogenic; D004791:Enzyme Inhibitors; D009153:Mutagens; D000077146:Irinotecan; D019772:Topotecan; D002166:Camptothecin